CancerVAX Biotech is a biotechnology company that develops universal cancer treatment using the body’s immune system.
CancerVAX Biotech has raised $903K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in May 2026.
CancerVAX Biotech is headquartered in Santa Barbara, United States.
CancerVAX Biotech is a biotechnology company that develops universal cancer treatment using the body’s immune system.
CancerVAX Biotech is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CancerVAX Biotech — Funding & Investors." VCBacked, May 1, 2026, https://www.vcbacked.co/company/cancervax-biotech. Accessed November 14, 2026.
VCBacked. (2026). CancerVAX Biotech — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/cancervax-biotech
{{cite web |title=CancerVAX Biotech — Funding & Investors |url=https://www.vcbacked.co/company/cancervax-biotech |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at CancerVAX Biotech? Request a listing update